Oric Pharmaceuticals (ORIC) Enterprise Value (2019 - 2026)
Oric Pharmaceuticals' (ORIC) quarterly Enterprise Value came in at -$281.9 million in Q1 2026, down 38.39% YoY from -$457.6 million in Q1 2025, and little changed on a QoQ basis from -$281.5 million in Q4 2025.
Oric Pharmaceuticals (ORIC) Enterprise Value (2019 - 2026) Analysis & Trends
Oric Pharmaceuticals (ORIC) has 8 years of Enterprise Value data on file, last reported at -$281.9 million in Q1 2026.
- Quarterly Enterprise Value fell 38.39% year-over-year to -$281.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$281.9 million (down 38.39% YoY) and the FY2025 annual result came in at -$281.5 million, down 9.97% from the prior year.
- Enterprise Value was little changed at -$281.9 million in Q1 2026, from -$281.5 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$189.6 million in Q1 2023 to a low of -$316.8 million in Q1 2024.
- A 5-year average of -$248.2 million and a median of -$256.0 million in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2024 — Enterprise Value plunged 67.05% — and 2025, when it jumped 35.69%.
- Tracing ORIC's Enterprise Value over 5 years: stood at -$206.3 million in 2022, then declined by 0.93% to -$208.2 million in 2023, then retreated by 22.95% to -$256.0 million in 2024, then decreased by 9.97% to -$281.5 million in 2025, then slipped by 0.16% to -$281.9 million in 2026.
- The last three Enterprise Value figures came in at -$281.9 million (Q1 2026), -$281.5 million (Q4 2025), and -$287.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Oric Pharmaceuticals | 1.44 Bn | 1.44 Bn | - | -264.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -264.76 Mn |
| Mar 31, 2026 | -281.93 Mn |
| Dec 31, 2025 | -281.49 Mn |
| Sep 30, 2025 | -287.14 Mn |
| Jun 30, 2025 | -282.51 Mn |
| Mar 31, 2025 | -203.72 Mn |
| Dec 31, 2024 | -255.96 Mn |
| Sep 30, 2024 | -272.37 Mn |
| Jun 30, 2024 | -286.41 Mn |
| Mar 31, 2024 | -316.78 Mn |
| Dec 31, 2023 | -208.19 Mn |
| Sep 30, 2023 | -227.30 Mn |
| Jun 30, 2023 | -264.16 Mn |
| Mar 31, 2023 | -189.63 Mn |
| Dec 31, 2022 | -206.27 Mn |
| Sep 30, 2022 | -193.66 Mn |
| Jun 30, 2022 | -227.06 Mn |
| Mar 31, 2022 | -234.62 Mn |
| Dec 31, 2021 | -236.98 Mn |
| Sep 30, 2021 | -289.52 Mn |